| ABHD16A |
O95870
|
abhydrolase domain containing 16A
|
Enzyme
|
0.47 |
0.861 |
0.269 |
| ATP6V1G2-DDX39B |
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
|
0.769 |
0.423 |
| C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
| C6orf47 |
O95873
|
chromosome 6 open reading frame 47
|
|
6.6E-02 |
0.722 |
0.423 |
| CUX2 |
O14529
|
cut like homeobox 2
|
Transcription factor
|
1.00 |
0.644 |
0.500 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| DDX39B |
Q13838
|
DExD-box helicase 39B
|
|
1.00 |
0.641 |
0.808 |
| GPSM3 |
Q9Y4H4
|
G protein signaling modulator 3
|
|
0.29 |
0.751 |
0.423 |
| HCG17 |
|
HLA complex group 17
|
|
|
0.769 |
0.346 |
| HCG18 |
|
HLA complex group 18
|
|
|
0.722 |
0.538 |
| HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| HLA-DOB |
P13765
|
major histocompatibility complex, class II, DO beta
|
Immune response
|
1.9E-06 |
0.705 |
0.500 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
| LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
| LST1 |
O00453
|
leukocyte specific transcript 1
|
|
1.1E-03 |
0.792 |
0.308 |
| MICA |
Q29983
|
MHC class I polypeptide-related sequence A
|
|
5.0E-03 |
0.473 |
0.846 |
| MICB |
Q29980
|
MHC class I polypeptide-related sequence B
|
|
4.1E-05 |
0.576 |
0.731 |
| MUC21 |
Q5SSG8
|
mucin 21, cell surface associated
|
|
8.0E-02 |
0.743 |
0.346 |
| MUCL3 |
Q3MIW9
|
mucin like 3
|
|
1.2E-05 |
0.691 |
0.731 |
| NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |
| POU5F1 |
Q01860
|
POU class 5 homeobox 1
|
|
0.95 |
0.441 |
0.846 |
| PRRC2A |
P48634
|
proline rich coiled-coil 2A
|
Enzyme
|
1.00 |
0.656 |
0.654 |
| PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |